(GSBD) Goldman Sachs BDC - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US38147U1079
Stock: Debt Investments, Equity Investments, Middle Market, Private
Total Rating 25
Risk 61
Buy Signal -0.32
| Risk 5d forecast | |
|---|---|
| Volatility | 16.8% |
| Relative Tail Risk | 1.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -21.35 |
| Character TTM | |
|---|---|
| Beta | 0.564 |
| Beta Downside | 0.893 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.59% |
| CAGR/Max DD | 0.02 |
EPS (Earnings per Share)
Revenue
Description: GSBD Goldman Sachs BDC March 04, 2026
Goldman Sachs BDC, Inc. (GSBD) operates as a business development company (BDC), focusing on debt and equity investments in private middle-market companies. BDCs are regulated investment vehicles that provide capital to developing firms, often those unable to access traditional bank financing.
GSBDs investment strategy emphasizes direct originations of secured and unsecured debt, including first lien, unitranche, and mezzanine debt, with a smaller allocation to equity. The fund targets investments between $10 million and $75 million in companies with annual EBITDA ranging from $5 million to $75 million. Mezzanine debt, for example, is a hybrid of debt and equity financing, typically used to finance the expansion of established companies.
For more detailed analysis of GSBDs portfolio and performance, consider exploring ValueRays comprehensive data.
Headlines to watch out for
- Middle market loan demand impacts new investment volume
- Interest rate fluctuations affect net investment income
- Credit quality of portfolio companies drives realized gains/losses
- Regulatory changes in BDC industry could restrict operations
- Economic downturns increase portfolio company defaults
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 119.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.88 > 1.0 |
| NWC/Revenue: -1.13% < 20% (prev 8.22%; Δ -9.35% < -1%) |
| CFO/TA 0.04 > 3% & CFO 125.3m > Net Income 119.3m |
| Net Debt (1.83b) to EBITDA (232.5m): 7.89 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.6m) vs 12m ago 0.79% < -2% |
| Gross Margin: 68.89% > 18% (prev 0.41%; Δ 6.85k% > 0.5%) |
| Asset Turnover: 8.73% > 50% (prev 5.34%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: 1.03 > 6 (EBITDA TTM 232.5m / Interest Expense TTM 111.6m) |
Altman Z'' -0.47
| A: -0.00 (Total Current Assets 70.1m - Total Current Liabilities 73.6m) / Total Assets 3.38b |
| B: -0.13 (Retained Earnings -456.7m / Total Assets 3.38b) |
| C: 0.03 (EBIT TTM 114.6m / Avg Total Assets 3.49b) |
| D: -0.23 (Book Value of Equity -456.6m / Total Liabilities 1.96b) |
| Altman-Z'' Score: -0.47 = B |
Beneish M
| DSRI: 0.61 (Receivables 26.9m/28.1m, Revenue 304.8m/192.4m) |
| GMI: 0.59 (GM 68.89% / 40.90%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.58 (Revenue 304.8m / 192.4m) |
| TATA: -0.00 (NI 119.3m - CFO 125.3m) / TA 3.38b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of GSBD shares?
As of March 18, 2026, the stock is trading at USD 9.29 with a total of 1,699,463 shares traded.
Over the past week, the price has changed by +1.42%, over one month by +0.86%, over three months by -1.13% and over the past year by -9.17%.
Over the past week, the price has changed by +1.42%, over one month by +0.86%, over three months by -1.13% and over the past year by -9.17%.
Is GSBD a buy, sell or hold?
Goldman Sachs BDC has received a consensus analysts rating of 2.50.
Therefor, it is recommend to sell GSBD.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the GSBD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.1 | -1.7% |
| Analysts Target Price | 9.1 | -1.7% |
GSBD Fundamental Data Overview March 18, 2026
P/E Trailing = 8.7961
P/E Forward = 10.7759
P/S = 2.8281
P/B = 0.7167
P/EG = 2.15
Revenue TTM = 304.8m USD
EBIT TTM = 114.6m USD
EBITDA TTM = 232.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.83b USD (from netDebt column, last quarter)
Enterprise Value = 2.87b USD (1.03b + Debt 1.88b - CCE 43.2m)
Interest Coverage Ratio = 1.03 (Ebit TTM 114.6m / Interest Expense TTM 111.6m)
EV/FCF = 22.90x (Enterprise Value 2.87b / FCF TTM 125.3m)
FCF Yield = 4.37% (FCF TTM 125.3m / Enterprise Value 2.87b)
FCF Margin = 41.09% (FCF TTM 125.3m / Revenue TTM 304.8m)
Net Margin = 39.12% (Net Income TTM 119.3m / Revenue TTM 304.8m)
Gross Margin = 68.89% ((Revenue TTM 304.8m - Cost of Revenue TTM 94.8m) / Revenue TTM)
Gross Margin QoQ = 85.55% (prev 49.69%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.87b / Total Assets 3.38b)
Interest Expense / Debt = 1.53% (Interest Expense 28.8m / Debt 1.88b)
Taxrate = 3.46% (850k / 24.6m)
NOPAT = 110.6m (EBIT 114.6m * (1 - 3.46%))
Current Ratio = 0.95 (Total Current Assets 70.1m / Total Current Liabilities 73.6m)
Debt / Equity = 1.32 (Debt 1.88b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 7.89 (Net Debt 1.83b / EBITDA 232.5m)
Debt / FCF = 14.65 (Net Debt 1.83b / FCF TTM 125.3m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.41% (Net Income 119.3m / Total Assets 3.38b)
RoE = 8.03% (Net Income TTM 119.3m / Total Stockholder Equity 1.48b)
RoCE = 3.46% (EBIT 114.6m / Capital Employed (Total Assets 3.38b - Current Liab 73.6m))
RoIC = 3.32% (NOPAT 110.6m / Invested Capital 3.33b)
WACC = 3.79% (E(1.03b)/V(2.91b) * Re(7.99%) + D(1.88b)/V(2.91b) * Rd(1.53%) * (1-Tc(0.03)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.71%
[DCF] Terminal Value 86.51% ; FCFF base≈155.6m ; Y1≈158.4m ; Y5≈173.7m
[DCF] Fair Price = 29.64 (EV 5.17b - Net Debt 1.83b = Equity 3.34b / Shares 112.6m; r=5.90% [WACC]; 5y FCF grow 1.57% → 2.90% )
EPS Correlation: -48.77 | EPS CAGR: -5.09% | SUE: 0.58 | # QB: 0
Revenue Correlation: 3.73 | Revenue CAGR: 13.63% | SUE: -1.36 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.004 | Chg30d=-0.004 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=1.23 | Chg7d=-0.048 | Chg30d=-0.072 | Revisions Net=-2 | Growth EPS=-21.4% | Growth Revenue=-11.4%
EPS next Year (2027-12-31): EPS=1.19 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Growth EPS=-3.7% | Growth Revenue=-3.5%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.4% (Discount Rate 8.0% - Earnings Yield 11.4%)
[Growth] Growth Spread = -6.4% (Analyst -9.8% - Implied -3.4%)
P/E Forward = 10.7759
P/S = 2.8281
P/B = 0.7167
P/EG = 2.15
Revenue TTM = 304.8m USD
EBIT TTM = 114.6m USD
EBITDA TTM = 232.5m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.83b USD (from netDebt column, last quarter)
Enterprise Value = 2.87b USD (1.03b + Debt 1.88b - CCE 43.2m)
Interest Coverage Ratio = 1.03 (Ebit TTM 114.6m / Interest Expense TTM 111.6m)
EV/FCF = 22.90x (Enterprise Value 2.87b / FCF TTM 125.3m)
FCF Yield = 4.37% (FCF TTM 125.3m / Enterprise Value 2.87b)
FCF Margin = 41.09% (FCF TTM 125.3m / Revenue TTM 304.8m)
Net Margin = 39.12% (Net Income TTM 119.3m / Revenue TTM 304.8m)
Gross Margin = 68.89% ((Revenue TTM 304.8m - Cost of Revenue TTM 94.8m) / Revenue TTM)
Gross Margin QoQ = 85.55% (prev 49.69%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.87b / Total Assets 3.38b)
Interest Expense / Debt = 1.53% (Interest Expense 28.8m / Debt 1.88b)
Taxrate = 3.46% (850k / 24.6m)
NOPAT = 110.6m (EBIT 114.6m * (1 - 3.46%))
Current Ratio = 0.95 (Total Current Assets 70.1m / Total Current Liabilities 73.6m)
Debt / Equity = 1.32 (Debt 1.88b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 7.89 (Net Debt 1.83b / EBITDA 232.5m)
Debt / FCF = 14.65 (Net Debt 1.83b / FCF TTM 125.3m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.41% (Net Income 119.3m / Total Assets 3.38b)
RoE = 8.03% (Net Income TTM 119.3m / Total Stockholder Equity 1.48b)
RoCE = 3.46% (EBIT 114.6m / Capital Employed (Total Assets 3.38b - Current Liab 73.6m))
RoIC = 3.32% (NOPAT 110.6m / Invested Capital 3.33b)
WACC = 3.79% (E(1.03b)/V(2.91b) * Re(7.99%) + D(1.88b)/V(2.91b) * Rd(1.53%) * (1-Tc(0.03)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.71%
[DCF] Terminal Value 86.51% ; FCFF base≈155.6m ; Y1≈158.4m ; Y5≈173.7m
[DCF] Fair Price = 29.64 (EV 5.17b - Net Debt 1.83b = Equity 3.34b / Shares 112.6m; r=5.90% [WACC]; 5y FCF grow 1.57% → 2.90% )
EPS Correlation: -48.77 | EPS CAGR: -5.09% | SUE: 0.58 | # QB: 0
Revenue Correlation: 3.73 | Revenue CAGR: 13.63% | SUE: -1.36 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.004 | Chg30d=-0.004 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=1.23 | Chg7d=-0.048 | Chg30d=-0.072 | Revisions Net=-2 | Growth EPS=-21.4% | Growth Revenue=-11.4%
EPS next Year (2027-12-31): EPS=1.19 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Growth EPS=-3.7% | Growth Revenue=-3.5%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.4% (Discount Rate 8.0% - Earnings Yield 11.4%)
[Growth] Growth Spread = -6.4% (Analyst -9.8% - Implied -3.4%)